Gastric MALT lymphoma

Also known as: 위말트 림프종 MALToma, 위몰트림프종

Doctors who treat Gastric MALT lymphoma

See all
Yonsei University Severance Hospital Kim Jin-seok

Kim Jin-seok

Yonsei University Severance Hospital · Hematology and Oncology

악성림프종,다발골수종,발작성야간성혈액소뇨증(PNH)

5.0
Seoul National University Hospital Byun Ja-min

Byun Ja-min

Seoul National University Hospital · Hematology and Oncology

만성 림프구성 백혈병, 다발골수종, 림프종, 세포치료, 조혈모세포이식, 신약임상

5.0
Hallym University Sacred Heart Hospital Han Bo-ram

Han Bo-ram

Hallym University Sacred Heart Hospital · Hematology and Oncology

백혈병, 골수형성이상증후군 등 악성혈액질환, 빈혈, 백혈구, 혈소판 감소 등 양성혈액질환

5.0
Samsung Seoul Hospital Kim Won-seok

Kim Won-seok

Samsung Seoul Hospital · Hematology and Oncology

림프종, CAR-T세포치료

5.0
Soonchunhyang University Seoul Hospital Kim Gyeong-ha

Kim Gyeong-ha

Soonchunhyang University Seoul Hospital · Hematology and Oncology

만성백혈병, 악성림프종, 다발성골수종, 조혈모세포이식, CAR-T 세포치료, 출혈성질환, 혈전클리닉(암 관련 혈전 질환 치료 및 예방), 빈혈, 기타 혈액질환

5.0
Seoul National University Hospital Ko Yeong-il

Ko Yeong-il

Seoul National University Hospital · Hematology and Oncology

림프구성백혈병, 혈액암, 림프종, 다발성골수종, 아밀로이드증, 혈소판감소증, 정밀의료, 임상시험, 맞춤치료

4.5
Yeouido St. Mary's Hospital, Catholic University of Korea Jeon Yeong-u

Jeon Yeong-u

Yeouido St. Mary's Hospital, Catholic University of Korea · Hematology and Oncology

CAR-T세포치료/이중항체치료,림프종,조혈모세포이식,면역세포치료,만성림프구성백혈병,캐슬만,형질세포이상증후군,야간혈색소 혈뇨증 (PNH), (혈액)희귀질환

4.5
Kyung Hee University Hospital Yoon Seong-su

Yoon Seong-su

Kyung Hee University Hospital · Hematology and Oncology

림프종, 다발성골수종, 양성혈액질환, 신약개발 임상시험

Seoul National University Bundang Hospital Lee Jeong-ok

Lee Jeong-ok

Seoul National University Bundang Hospital · Hematology and Oncology

혈액암 (림프종, 급성림프모구백혈병, 만성백혈병),조혈모세포이식, CAR-T 세포치료, 혈액질환

Seoul National University Bundang Hospital Lee Ji-yun

Lee Ji-yun

Seoul National University Bundang Hospital · Hematology and Oncology

혈액암 (다발골수종), 조혈모세포이식, CAR-T 세포치료, 혈액질환

Disease Description (Causes and Symptoms)

  • Definition summary: Burkitt lymphoma is a highly malignant non-Hodgkin lymphoma originating from B cells. It has a very high proliferation rate and is a rapidly growing tumor. It is characterized by a “starry-sky” appearance on cytology and translocations of the MYC gene (t(8;14), t(2;8), t(8;22)).
  • Causes/associated factors:
    • Impaired regulation of cell proliferation due to MYC gene translocation.
    • Epstein–Barr virus (EBV) infection: strongly associated with the endemic form. It is also associated with immunosuppression (e.g., HIV and immunosuppression after transplantation).
    • The exact single cause is unknown.
  • Pathophysiology:
    • Because of the very high cell proliferation rate (Ki‑67 ≒ 100%), a large tumor burden, cell necrosis and hemorrhage, and central nervous system (CNS) involvement may develop within a short period.
  • Main symptoms:
    • Children and adolescents: acute abdominal pain, an abdominal mass (which may cause intestinal obstruction or intestinal ischemia), vomiting, weight loss, anemia, and signs of bleeding.
    • Adults (sporadic form): involvement of abdominal organs (such as the ileum and peritoneum) is common.
    • Face and jaw (endemic form), enlarged lymph nodes, fever, night sweats, and fatigue.
    • With CNS involvement: headache, vomiting, neurological deficits, and altered consciousness.

Treatment (Standard Treatment, Medications, Procedures, Lifestyle Management, and Precautions)

  • Active and rapid treatment is required after confirmation of the diagnosis (because of the rapid progression).
  • Overview of standard treatment:
    • Intensive (high-intensity) combination chemotherapy is standard. In children, LMB-based regimens are used; in adults, CODOX-M/IVAC, Hyper-CVAD, or intensive combination regimens are used. Rituximab (anti-CD20) is combined in most cases when the disease is CD20-positive to improve the survival rate.
    • CNS prevention and treatment: CNS prophylaxis (or treatment) is performed using intrathecal (IT) methotrexate, cytarabine, and other agents, together with high-dose systemic methotrexate.
    • Hematopoietic stem cell transplantation: considered in patients with relapse or refractory disease. Autologous (autologous hematopoietic stem cell transplantation) or allogeneic transplantation is decided on an individual basis.
    • Surgery/radiation: limited except for tissue biopsy for diagnosis. Surgical treatment may be required for complications such as intestinal obstruction or bleeding.
  • Supportive care and side-effect management:
    • Prevention of tumor lysis syndrome: fluid administration, uric acid-lowering drugs (Allopurinol or Rasburicase), electrolyte monitoring (potassium, phosphorus, and calcium), and attention to kidney function.
    • Infection prevention and management: use of antibiotics, antifungal agents, and antiviral agents; growth factors (G‑CSF) may be considered in cases of neutropenia.
    • Transfusions (for anemia or bleeding), antiemetics, and nutritional management.
    • Fertility preservation counseling (sperm and egg preservation counseling is recommended before chemotherapy).
  • Precautions and risk of complications:
    • Delaying rapid treatment worsens the prognosis. Hospitalization and inpatient treatment are common.
    • Complications: tumor lysis syndrome, heart failure (with certain medications), severe bone marrow suppression, infection, neurological complications, intestinal perforation, and bleeding.
  • Prognosis:
    • In children and adolescents, active treatment results in a high cure rate (often reported to be over 80%). In adults, the prognosis varies more depending on the indication, stage, CNS involvement, and underlying disease.

Checklist Before an Outpatient Visit (Including Items to Bring and Example Questions)

  • Items to bring:
    • A list of all medications currently being taken (prescription drugs, over-the-counter drugs, herbal medicines, and supplements)
    • Records of allergies (medications, foods, etc.)
    • Recent test results (blood tests, imaging tests, etc.) or related reports
    • A record of symptom changes (when they began, how quickly they progressed, weight changes, fever, bleeding, changes in bowel movements, etc.)
    • Contact information for a caregiver or designated contact person
  • Items that are useful to record during medical visits:
    • Presence of fever and temperature records, urine output, gastrointestinal symptoms (vomiting, diarrhea, abdominal pain), and neurological symptoms (headache, visual disturbances, weakness)
  • Precautions before an outpatient visit:
    • If fever or acute symptoms (acute abdominal pain, difficulty breathing, significant bleeding, etc.) occur, visiting an emergency room is recommended.
    • Regular blood tests, kidney function tests, and electrolyte tests are necessary.
  • Example questions (to note down for the doctor):
    • "What tests should be checked during this visit, and what imaging tests are scheduled?"
    • "Are there any tests or vaccinations I need to prepare for before starting treatment?"

Examples of General Questions to Ask the Doctor

  • What are the main side effects of this medication (or treatment), and how should I respond if they occur?
  • What is the treatment plan and expected treatment duration based on my stage (and test results)?
  • What measures are taken to prevent tumor lysis syndrome? Is inpatient treatment necessary?
  • How should I adjust my daily activities (meals, exercise, work, and school) during treatment?
  • What options should I consider to preserve fertility?

Examples of Disease-Specific Questions

  • In my case (including CNS test results and whether there is bone marrow involvement), is CNS prophylaxis (IT injection or high-dose methotrexate) necessary? How many treatments will be needed and over what period?
  • How do the presence or absence of a MYC translocation and EBV status affect treatment selection or prognosis? Are additional genetic or molecular tests necessary?

(Note: This summary is intended to provide general information about diagnosis and treatment. Specific diagnosis and treatment plans should be determined through consultation with the treating doctor.)

Patient stories: Gastric MALT lymphoma

Talk with other Gastric MALT lymphoma patientsAsk people who have been through itWrite

Hospitals that treat Gastric MALT lymphoma

University hospitals where the doctors above see patients. Open a hospital to see its doctors by specialty and how to book.

Other conditions in Hematology and Oncology

Condition guide
Find top doctors for 'Gastric MALT lymphoma'

Reviewed by · GoodDoctorNet medical specialists

This information is for general understanding only and does not replace diagnosis, prescription or treatment for an individual patient. If you have symptoms, please see a doctor.

Our medical content policy (in Korean) →